Condition
Neuroendocrine Tumor clinical trials and research
Research outlook What's coming for Neuroendocrine tumors: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 5 Neuroendocrine Tumor clinical trials that are recruiting, at sites in 3 countries (most in United States (3), China (1), France (1)). By phase: Early Phase 1 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest Neuroendocrine Tumor clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| PET/CT imaging with [68Ga] Ga-FAPI-04 for people with high-grade neuroendocrine cancer | Early Phase 1 | Ann Arbor, Michigan | Recruiting | Aug 20, 2025 |
| Breathing practice to improve brain and mental health in cancer and MS patients | — | Rochester, Minnesota | Recruiting | Jan 23, 2025 |
| Using 18F-MFBG PET/CT to evaluate neural crest tumors | Early Phase 1 | Beijing, Dongcheng | Recruiting | Oct 6, 2021 |
| Using virtual reality to help manage pain in GI cancer patients | — | Los Angeles, California | Recruiting | Jun 1, 2021 |
| Intra-arterial liver infusion of radiolabeled somatostatin drugs for gastroenteropancreatic neuroendocrine tumors with dominant liver metastases | Phase 2 | Bordeaux and 3 other locations | Recruiting | Apr 8, 2021 |
All recruiting trials (5)
-
PET/CT imaging with [68Ga] Ga-FAPI-04 for people with high-grade neuroendocrine cancer
This will test if a PET/CT scan using [68Ga] Ga-FAPI-04 can find high-grade neuroendocrine cancer in adults.
-
Breathing practice to improve brain and mental health in cancer and MS patients
This study tests whether breathing exercises through a mobile app can help improve brain and mental health for people with cancer and multiple sclerosis, along with their caregivers.
-
Using 18F-MFBG PET/CT to evaluate neural crest tumors
This study is testing a new imaging method using 18F-MFBG to see if it can help diagnose and better understand tumors like pheochromocytoma, paraganglioma, and neuroblastoma in patients.
-
Using virtual reality to help manage pain in GI cancer patients
This study is testing if virtual reality can help people with GI cancer manage their severe abdominal pain better than standard treatments.
-
Intra-arterial liver infusion of radiolabeled somatostatin drugs for gastroenteropancreatic neuroendocrine tumors with dominant liver metastases
This will test whether giving radiolabeled somatostatin medication directly into the liver works better than the usual IV route for people with gastroenteropancreatic neuroendocrine tumors whose disease mainly affects the liver after four Lutathera treatments.
Related topics
Quick answers
How many Neuroendocrine Tumor clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (3 trials), China (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.